Exploring the druggability of oxidized low-density lipoprotein (ox-LDL) receptor, LOX-1, a proatherogenic drug target involved in atherosclerosis is a research paper published in Biochemical and Biophysical Research Communications (2022). On theSindex it has a DataRank of 0. It has been cited 8 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Indian Council of Medical Research
Grant: NCD/Adhoc/216/2021–2022
U.S. Department of Veterans Affairs
Grant: I01BX000282
Department of Biotechnology, Ministry of Science and Technology, India
Grant: BT/PR28080/BID/7/836/2018
Department of Biotechnology, Ministry of Science and Technology, India
Grant: BT/PR28766/BRB/10/1701/2018
Department of Biotechnology, Ministry of Science and Technology, India
Grant: BT/PR40154/BTIS/137/34/2021
Department of Science and Technology, Ministry of Science and Technology, India
Grant: PDF/2016/000171
National Cancer Institute
University Grants Commission
National Institutes of Health
University of Arkansas for Medical Sciences
Biomedical Laboratory Research and Development, VA Office of Research and Development
MeSH Terms
Keywords